CGM for Insulin-Treated T2DM During Post-Discharge Transition
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT07414277
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT07414277
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07414277. Randomized; no masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CGM for Insulin-Treated T2DM During Post-Discharge Transition
- Acronym
- TRANSIT-CGM
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Device)
- RT-CGM
- Intervention (Device)
- SMBG
- Lead sponsor
- Shanghai 6th People's Hospital
- Collaborator
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator
- Shanghai Fengxian District Central Hospital
- Collaborator
- Shanghai 7th People's Hospital
Record details
- Record id
cardio:ct-nct07414277- Content hash
62ba114520d62cbde284171b1f57ccfba44c387c442810ffd017399eb3fd592b